Prevention of heterotopic ossifications in hip arthroplasty: Effectiveness of selective Cox-2 inhibitors (celecoxib) versus ketoprofen;Comparaison célécoxib versus kétoprofène pour la prévention des ossifications péri-prothétiques de hanche: Étude pilote prospective

Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur

Volumn 91, Issue 1, 2005, Pages 64-69

  Vastel, L ^a   Rosencher, N ^a   Siney, H ^a   Courpied, J P ^a  

^a université Paris Cité   (France)

Author keywords

Celecoxib; Hip; Ossification; Prevention; Prosthesis

Indexed keywords

ANTIINFLAMMATORY AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; KETOPROFEN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FISHER EXACT TEST; GENDER; HETEROTOPIC OSSIFICATION; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT;

EID: 14144252659     PISSN: 00351040     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-1040(05)84277-1     Document Type: Article

References (21)

1. DELEE J, FERRARI A, CHARNLEY J: Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop, 1976, 121, 53-59.
2. HAMBLEN DL, HARRIS WH, ROTTGER J: Myositis ossificans as a complication of hip arthroplasty. J Bone Joint Surg (Br), 1971, 53, 764-768.
3. POSTEL M, KERBOUL M, EVRARD J, COURPIED JP: in « Arthroplastie totale de hanche », 1985, Springer verlag, Berlin Heidelberg.
4. VASTEL L, KERBOULL L, ANRACT P, KERBOULL M: Heterotopic ossification after total hip arthroplasty: Risk factors and prevention. Rev Rhum Engl Ed, 1998, 65, 238-244.
5. CHARNLEY J: The long term results of low friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg (Br), 1972, 54, 61-76.
6. GOUTALLIER D, COLMAR M, PENOT P: Ossifications périprothé tiques de hanche: Influence de la durée de traitement postopératoire par indometacine et rôle de l'ossification du ligament tranverse de l'acetabulum dans la survenue des ossifications. Rev Chir Orthop, 1993, 79, 22-28.
7. COVENTRY MB, SCANLON PW: The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip. J Bone Joint Surg (Am), 1981, 63, 201-208.
8. AYERS DC, MC COLLISTER EVARTS C, PARKINSON JR: The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg (Am), 1986, 68, 1423-1438.
9. BREMEN-KUHNE R, STOCK D, FRANKE C: Indomethacin-short-term therapy vs, single low dosage radiation for prevention of periarticular ossifications after total hip endoprosthesis. Z Orthop, 1997, 135, 422-429.
10. SEEGENSCHMIEDT MH, MAKOSKI HB, MICKE O: Radiation prophylaxis for heterotopic ossification about the hip joint - A multicenter study: German cooperative group on radiotherapy for benign deseases. Int J Radiat Oncol Biol Phys, 2001, 51, 756-765.
11. DAHL HK: Clinical observations in Symposium on Arthrose: Proceedings of a conference, 1974, MSD, Blinder (Norway).
12. FRIEBERG AA, CANTOR R, FREIBERG AR: The use of aspirin to prevent heterotopic ossification after THA. Clin Orthop, 1991, 267, 93-96.
13. GEBURH P, SOELBERG M, ORNES T: Naproxen prevention of heterotopic ossifications after hip arthroplasty. Acta Orthop Scand, 1991, 62, 226-229.
14. PERSSON PE, SODEMANN B, NILSSON OS: Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double blind prospective study of treatment time. Acta Orthop Scand, 1998, 69, 111-115.
15. KJAERGAARD-ANDERSEN P, SCHMIDT SA: Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand, 1986, 57, 12-14.
16. VANE JR: Inhibition of Prostaglandins synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol, 1971, 231, 232-235.
17. EYB R, KNARH K: The effect of prophylaxis for thrombosis on heterotopic ossifications following total hip joint replacement. Arch Orthop Surg, 1985, 102, 114-117.
18. BARTHEL T, BAUMANN B, NOTH U, EULERT J: Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta orthop Scand, 2002, 73, 611-614.
19. LEGENSTEIN R, BOSCH P, UNGERSBOCK A: Indomethacin versus meloxicam for prevention of heterotpic ossification after total hip arthroplasty. Arch Orthop Trauma Surg, 2003, 123, 91-94.
20. VASTEL L, KERBOULL L, DEJEAN O, COURPIED JP, KERBOULL M: Prevention of heterotopic ossification in hip arthroplasty. The influence of the duration of treatment. Int Orthop, 1999, 23, 107-110.
21. BROOKER AF, BOWERMAN JW, ROBINSON RA: Ectopic ossification following total hip replacement: incidence and a method of classification. J Bone Joint Surg (Am), 1973, 55, 1629-1633.